Fulgent Genetics Inc (NASDAQ: FLGT) is -19.04% lower on its value in year-to-date trading and has touched a low of $23.09 and a high of $44.09 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FLGT stock was last observed hovering at around $25.48 in the last trading session, with the day’s loss setting it -2.07%.
Currently trading at $23.41, the stock is -6.55% and -12.66% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.88 million and changing -8.14% at the moment leaves the stock -24.34% off its SMA200. FLGT registered -28.36% loss for a year compared to 6-month loss of -30.34%. The firm has a 50-day simple moving average (SMA 50) of $0.80 and a 200-day simple moving average (SMA200) of -$4.43.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -10.80% gain in the last 1 month and extending the period to 3 months gives it a -15.23%, and is -4.39% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.85% over the week and 3.70% over the month.
Fulgent Genetics Inc (FLGT) has around 1012 employees, a market worth around $693.49M and $286.41M in sales. Profit margin for the company is -22.17%. Distance from 52-week low is 1.36% and -46.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-5.01%).
Fulgent Genetics Inc quarterly earnings per share for the current quarter are estimated at -$0.29 with sales reaching $66.32M over the same period.The EPS is expected to shrink by -180.51% this year, but quarterly earnings will post -54.00% year-over-year. Quarterly sales are estimated to shrink -2.00% in year-over-year returns.
287 institutions hold shares in Fulgent Genetics Inc (FLGT), with institutional investors hold 72.49% of the company’s shares. The shares outstanding are 29.44M, and float is at 19.16M with Short Float at 2.70%. Institutions hold 49.61% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 3.63 million shares valued at $134.4 million. The investor’s holdings represent 12.13% of the FLGT Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 1.39 million shares valued at $51.49 million to account for 4.65% of the shares outstanding. The other top investors are Dimensional Fund Advisors LP which holds 1.05 million shares representing 3.50% and valued at over $38.75 million, while State Street Corporation holds 2.53% of the shares totaling 0.76 million with a market value of $28.0 million.
Fulgent Genetics Inc (FLGT) Insider Activity
A total of 12 insider transactions have happened at Fulgent Genetics Inc (FLGT) in the last six months, with sales accounting for 12 and purchases happening 0 times. The most recent transaction is an insider sale by Xie Jian, the company’s President and COO. SEC filings show that Xie Jian sold 22,000 shares of the company’s common stock on Dec 11 at a price of $26.52 per share for a total of $0.58 million. Following the sale, the insider now owns 0.36 million shares.
Fulgent Genetics Inc disclosed in a document filed with the SEC on Dec 04 that Xie Jian (President and COO) sold a total of 1,779 shares of the company’s common stock. The trade occurred on Dec 04 and was made at $27.57 per share for $49053.0. Following the transaction, the insider now directly holds 0.39 million shares of the FLGT stock.
Still, SEC filings show that on Dec 04, Kim Paul (CFO and Treasurer) disposed off 1,437 shares at an average price of $27.57 for $39623.0. The insider now directly holds 200,460 shares of Fulgent Genetics Inc (FLGT).
Fulgent Genetics Inc (FLGT): Who are the competitors?
One of the company’s main competitors (and peers) include NeoGenomics Inc. (NEO) that is trading -6.15% down over the past 12 months.Invitae Corp. (NVTAQ) lies in the list of competitors of the Fulgent Genetics Inc and is -99.34% lower over the same period from FLGTNatera Inc. (NTRA) is 41.03% up on the 1-year trading charts.
